Track topics on Twitter Track topics that are important to you
Bristol-Myers Squibb has invested $12 million in Compugen, a biotech that is investigating a new approach that could boost the effectiveness of its blockbuster cancer immunotherapy Opdivo. BMS said i...
NEW YORK CITY (dpa-AFX) - Bristol-Myers Squibb Company (BMY) and Compugen (CGEN) announced a clinical trial collaboration to evaluate the safety and tolerability of Compugen's COM701, an investiga...
Tel Aviv, Israel, July 30, 2018 – BioLineRx Ltd. (NASDAQ/TASE:BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today the expansion of its immuno-on...
BioLineRx has commenced a Phase l/lla clinical trial to investigate the safety and tolerability of AGI-134 for the treatment of...Read More... The post BioLineRx starts Phase l/lla trial of AGI-134 fo...
The continued development of cancer drug BAY 1905254 is a major boost for Compugen's ability to successfully identify new mechanisms for treatments using its big data systems.
Bristol-Myers Squibb and Israel-based Compugen said they will collaborate in clinical trials for patients with advanced solid tumors.
In this episode of PharmaTelevision News Review, filmed in Amsterdam at BioEurope Spring 2012, Fintan Walton talks to David Malek, Vice Preident of Business Development of BioLineRx.
BioLineRx Ltd. is a publicly-traded biopharmaceutical development company. It is dedicated to building a portfolio of products for unmet medical needs or with advantages over curr...
BioLineRx's ultimate mission is to improve the health of people throughout the world with compounds that make for better and longer lives. Founded in 2003 by leaders in the Israeli life-sciences secto...
Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are b...
Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen’s discovery efforts are based...
Compugen is a leading therapeutic product discovery company focused on therapeutic proteins and monoclonal antibodies to address important unmet needs in the fields of immunology ...
We have published hundreds of BioLineRx Ltd. and Compugen Ltd. news stories on BioPortfolio along with dozens of BioLineRx Ltd. and Compugen Ltd. Clinical Trials and PubMed Articles about BioLineRx Ltd. and Compugen Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioLineRx Ltd. and Compugen Ltd. Companies in our database. You can also find out about relevant BioLineRx Ltd. and Compugen Ltd. Drugs and Medications on this site too.
Psychiatry is the study of mental disorders and their diagnosis, management and prevention. Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...